Department of Surgery, University of Auckland, Auckland, New Zealand.
Br J Surg. 2014 Dec;101(13):1644-56. doi: 10.1002/bjs.9665. Epub 2014 Oct 21.
The gut is implicated in the pathogenesis of acute pancreatitis but there is discrepancy between individual studies regarding the prevalence of gut barrier dysfunction in patients with acute pancreatitis. The aim of this study was to determine the prevalence of gut barrier dysfunction in acute pancreatitis, the effect of different co-variables, and changes in gut barrier function associated with the use of various therapeutic modalities.
A literature search was performed using PRISMA and MOOSE guidelines. Summary estimates were presented as pooled prevalence of gut barrier dysfunction and the associated 95 per cent c.i.
A total of 44 prospective clinical studies were included in the systematic review, of which 18 studies were subjected to meta-analysis. The pooled prevalence of gut barrier dysfunction was 59 (95 per cent c.i. 48 to 70) per cent; the prevalence was not significantly affected by disease severity, timing of assessment after hospital admission or type of test used, but showed a statistically significant association with age. Overall, nine of 13 randomized clinical trials reported a significant improvement in gut barrier function following intervention compared with the control group, but only three of six studies that used standard enteral nutrition reported a statistically significant improvement in gut barrier function after intervention.
Gut barrier dysfunction is present in three of five patients with acute pancreatitis, and the prevalence is affected by patient age but not by disease severity. Clinical studies are needed to evaluate the effect of enteral nutrition on gut function in acute pancreatitis.
肠道与急性胰腺炎的发病机制有关,但关于急性胰腺炎患者肠道屏障功能障碍的患病率,各个研究之间存在差异。本研究旨在确定急性胰腺炎患者肠道屏障功能障碍的患病率,不同协变量的影响,以及与各种治疗方式相关的肠道屏障功能变化。
采用 PRISMA 和 MOOSE 指南进行文献检索。汇总估计值以肠道屏障功能障碍的 pooled 患病率和相关的 95%置信区间(CI)呈现。
系统评价共纳入 44 项前瞻性临床研究,其中 18 项进行了荟萃分析。肠道屏障功能障碍的 pooled 患病率为 59%(95%CI:48%至 70%);患病率不受疾病严重程度、住院后评估时间或使用的检测类型的影响,但与年龄呈统计学显著关联。总体而言,13 项随机临床试验中有 9 项报告干预后肠道屏障功能显著改善,而在 6 项使用标准肠内营养的研究中,只有 3 项报告干预后肠道屏障功能有统计学显著改善。
急性胰腺炎患者中有五分之三存在肠道屏障功能障碍,其患病率受患者年龄影响,但不受疾病严重程度影响。需要开展临床研究来评估肠内营养对急性胰腺炎患者肠道功能的影响。